Sufianova, Galina,
Sufianova, Galina,
Beylerli, Ozal,
Wu, Jianing,
Shumadalova, Alina,
Sufianov, Albert,
Chen, Xin,
Zhao, Shiguang (2022) Modern aspects of the use of natural polyphenols in tumor prevention and
therapyBeylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) -tumor barrier (BTB), which limit the efficacy of systemic
therapies. Recent advances in molecular biology
of the potential of immune system-derived miRNAs to revolutionize CVD management and
therapy, addressing a major
Chmutin, G,
Antonov, G,
Chmutin, E,
Fedyanin, A,
Livshitz, M,
Oleynikov, B,
Zokhidov, Z,
Shumadalova, A (2022) . The progression of the VBI, especially in the context of inadequate
therapy, often leads to the formation of a
ОПТИМИЗАЦИЯ ПОДДЕРЖИВАЮЩЕЙ ПАРОДОНТАЛЬНОЙ ТЕРАПИИ У ПАЦИЕНТОВ ГРУППЫ РИСКА С ДЕНТАЛЬНЫМИ ИМПЛАНТАТАМИГУЛЯЕВА, О.А.,
АВЕРЬЯНОВ, С.В.,
ЯКУПОВ, Б.А.,
Gulyaeva, O.A.,
Averyanov, S.V.,
Yakupov, B.A. (2019) по протоколу Guided Biofilm
Therapy (GBT), II группы - по классическому протоколу. В I группе
Prostatakarzinoms: Eine medizinhistorische Bestandsaufnahme anlässlich 20 Jahre robotisch assistierter
Therapie (Der